Prevalence and Consequences of Androgen Deficiency in Young Male Cancer Survivors in a Controlled Cross-Sectional Study | Zendy

David Greenfield | Zendy; Stephen J. Walters | Zendy; Robert E. Coleman | Zendy; Barry W. Hancock | Zendy; Richard Eastell | Zendy; Helena Davies | Zendy; John A. Snowden | Zendy; Leonard R. Derogatis | Zendy; Stephen M. Shalet | Zendy; Richard Ross | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prevalence and Consequences of Androgen Deficiency in Young Male Cancer Survivors in a Controlled Cross-Sectional Study

Author(s) -

David Greenfield,

Stephen J. Walters,

Robert E. Coleman,

Barry W. Hancock,

Richard Eastell,

Helena Davies,

John A. Snowden,

Leonard R. Derogatis,

Stephen M. Shalet,

Richard Ross

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2006-2744

Subject(s) - medicine , androgen deficiency , testosterone (patch) , endocrinology , sexual function , confidence interval , androgen , cross sectional study , cancer , sex hormone binding globulin , hormone , pathology

Testosterone replacement in hypogonadal males improves body composition, sexual function, and health-related quality of life. Male cancer survivors are at risk of androgen deficiency; however, when and in whom testosterone should be replaced remain unanswered questions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research